Basic information
Biomarker: desmoglein
Histology type: endometrial carcinoma
Cohort characteristics
Country: Japan
Region: Sapporo
Followed up time :
| Total number | Group I | Group I number | Group II | Group II number | Group III | Group III number | Group IV | Group IV number |
|---|---|---|---|---|---|---|---|---|
| 77 | EC | 41 | atypical hyperplasia | 5 | normal endometrium | 31 |
Sample information
Conclusion: Reduction of desmoglein expression may play an important role in the invasiveness and metastatic activity of human endometrial carcinoma. They can therefore be used as differentiation markers for endometrial carcinoma.
Sample type : tissue
Sample method: immunofluorescence
Expression pattern : expression
Disease information
Related information
UniProt Link: https://www.uniprot.org/uniprotkb?query=desmoglein
Molecular function from UniProt:
HPA link: https://www.proteinatlas.org/search/desmoglein
HGNC link: https://www.genenames.org/tools/search/#!/?query=desmoglein
